Epitalon vs Pinealon
Both Epitalon and Pinealon are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.
Epitalon
Evidence C+Epitalon (Epithalon, AEDG)
A synthetic tetrapeptide that reportedly upregulates telomerase activity. Russian longevity studies suggest mortality reductions but Western RCTs are absent.
View full Epitalon profile →Pinealon
Evidence CPinealon (EDR)
A short tripeptide developed in Russia for cognitive aging and oxidative stress. Limited Western clinical evidence.
View full Pinealon profile →Side-by-Side
| Attribute | Epitalon | Pinealon |
|---|---|---|
| Evidence Grade | C+ | C |
| FDA Status | Not FDA-approved — Russian-origin research peptide | Not FDA-approved — Russian-origin research peptide |
| Typical Dose | 5–10 mg daily for 10–20 days, cycled (subcutaneous) | 5–10 mg daily for 10–20 days (subcutaneous, cycled) |
| Clinics Indexed | 47 | 9 |
| Categories | anti-aging, longevity | cognitive, longevity |
Key reported benefits — Epitalon
- ✓Telomerase upregulation (preclinical)
- ✓Sleep/circadian normalization
- ✓Anti-aging signals
Key reported benefits — Pinealon
- ✓Cognitive function (preclinical)
- ✓Reduced oxidative damage
- ✓Sleep/circadian effects
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.